Navigation Links
U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
Date:11/20/2009

BOSTON, Nov. 20 /PRNewswire/ -- The United States Court of Appeals for the First Circuit upheld an earlier District Court ruling yesterday, approving a settlement in the long-running Average Wholesale Price (AWP) pharmaceutical litigation against AstraZeneca Pharmaceuticals ( AZN).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080317/AQM144LOGO)

The ruling affirms a settlement that awarded consumers who purchased the pharmaceutical giant's prostate cancer drug Zoladex treble damages, a rare if not unprecedented event in consumer litigation.

The case, argued by Steve W. Berman a Seattle plaintiff's attorney with Hagens Berman Sobol Shapiro (HBSS), afforded thousands of consumers access to a $24 million settlement against the drug giant accused of manipulating the price of Zoladex.

Under the settlement approved by the U.S. District Court in November 2007, any consumer who could provide reasonable documentation can receive three times the actual damages. Any funds left over from the $24 million settlement would go to non-profit organizations. Experts representing the plaintiffs expect that only about $21 million will be claimed by class members, many of whom have passed away since the case was filed.

The distribution to charities falls under a legal doctrine cy pre, a Norman French expression for "as near as it comes," allowing for the unclaimed amount of the settlement to benefit those in the class, even if indirectly.

This is the first time the First Circuit has affirmed the use of cy pre in this way.

The ruling was in response to an appeal filed by a class member who objected to the settlement, claiming the cy pre fund lowered the amount of recovery to class members. The objecting claimant also argu
'/>"/>

SOURCE Hagens Berman Sobol Shapiro
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
2. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
3. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
4. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
5. Jubilant Enters Research Collaboration With AstraZeneca
6. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
7. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
8. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
9. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
10. AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
11. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- It is no secret that ... being overweight or obese gyms and supplement companies are in ... condition is primarily related to dietary issues and a lack ... result of a glandular problem or even a vitamin deficiency. ... vitamin deficiency is a lack of vitamin b12 . ...
(Date:5/20/2013)... 2013   National Community Pharmacists Association (NCPA) ... MBA issued the following statement today regarding a ... D "preferred pharmacy" drug plans , which often ... lowest advertised co-payments: (Logo:  http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ... MedPAC , 16 U.S. Senators and ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ... treatment-failure gout will be reviewed by the Arthritis Advisory Committee ... March 5, 2009 as required for a drug of a ... to the FDA on October 31, 2008 seeking approval to ...
... Stock to trade under new ticker symbol ,CDXP.OB, LA ... Bulletin Board: DSKA) announced today that it has completed ... a result of the name change, the Over-the-Counter Bulletin ... ticker symbol OTCBB: CDXP.OB.James S. Kuo, M.D., Cordex,s Chief ...
Cached Medicine Technology:Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 2Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 3Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients 4Duska Therapeutics Completes Corporate Name Change to Cordex Pharma 2Duska Therapeutics Completes Corporate Name Change to Cordex Pharma 3
(Date:5/21/2013)... Romio , an innovative online local ... businesses, announced today that it will be releasing short ... Medical Care is located in Tribeca and Clinton and ... The guarantee of seeing a doctor within 20 ... the neighborhood and a great alternative to long waits ...
(Date:5/21/2013)... AAG Health, the leading age management ... that it has acquired the OligoScan test made by ... advanced spectrophotometry technology, the OligoScan device is capable of ... 14 heavy metals, 20 trace elements (minerals), and oxidative ... substances such as mercury, lead, aluminum, and arsenic, will ...
(Date:5/21/2013)... Alan Mozes HealthDay Reporter , , MONDAY, ... used by millions of people with chronic obstructive ... cardiovascular complications among older patients, a new large ... patients over age 65 who are prescribed long-acting ... beta-agonists (such as Serevent). Both medications are commonly ...
(Date:5/21/2013)... exist in the treatment of non-small cell lung cancer ... large new study. Although most patients with this ... researchers found that blacks were less likely than Hispanics ... of the disease. Hispanics were more likely to undergo ... white patients. "In our study of more than ...
(Date:5/21/2013)... ─ The negative effects of poorly controlled asthma ... urban schoolchildren has been confirmed in a new ... that missed sleep and school absences are important ... is the first to explore the associations between ... time, prospectively, using both objective and subjective ...
Breaking Medicine News(10 mins):Health News:Romio Announces Mini Video Series Featuring Local Business Emergency Medical Care 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2Health News:Asthma symptoms impair sleep quality and school performance in children 2
... , ... Idea Box Consulting, a leader in CRM ... management consulting firm, to help Salesforce users maximize revenues and results ... HPSE is a metric-driven sales and sales management methodology from ...
... ... ... Children’s National Medical Center is one of only eight children’s hospitals in the country named ... the Leapfrog Hospital survey, which focuses on objective measures and processes that ensure quality and ...
... Six Weeks of Antidepressants - Don,t Stop Treatment Too Early ... after six weeks of antidepressants but a new study published ... hazardous to stop treatment at this point. , A key ... during clinical depression and does not normalize after six weeks ...
... , SILVER ... make a lifestyle change in 2010? Discovery Health presents NEW ... and shocking stories of personal transformation that will inspire audiences to ... Doctor, to the relatable tale of a lapsed reality star, to ...
... , , WASHINGTON, Dec. 10 ... to protecting flexible spending accounts (FSAs), today launched a ... voice their support for protecting the cost-saving benefit by ... of 2010. The campaign coincides with the Senate,s consideration ...
... The National Institutes of Health is launching a ... basic research on human behavior to develop more ... Translating Basic Behavioral and Social Science Discoveries into ... of researchers at seven research sites. Investigators ...
Cached Medicine News:Health News:Salesforce CRM Users Outperform Past Results by a Factor of at Least 50% 2Health News:Salesforce CRM Users Outperform Past Results by a Factor of at Least 50% 3Health News:Children's National Named to the 2009 Leapfrog Group Best Hospitals List 2Health News:Children's National Named to the 2009 Leapfrog Group Best Hospitals List 3Health News:Most Antidepressants Miss Key Target of Clinical Depression 2Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 2Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 3Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 4Health News:Senate Restrictions on Flexible Spending Accounts Spur New Campaign 2Health News:Senate Restrictions on Flexible Spending Accounts Spur New Campaign 3Health News:NIH launches program to develop innovative approaches to combat obesity 2Health News:NIH launches program to develop innovative approaches to combat obesity 3
... is a state-of-the-art hair reduction and ... specially designed for use within a ... features and economy in a single ... treatment of unwanted hair, photo rejuvenation ...
... perfect mix of powerful, versatile, and innovative ... Palomar StarLux® Pulsed Light and Laser System.,With ... compact base unit so theres no ... treatments., You can choose among Laser, Intense ...
Perfect for physicians who prefer a Heavier and Longer tubing, permitting them maximum access around the OR table. 12 feet in length Sizes availabe to fit any vacuum canisters...
... Pump provides optimum flow rate ... Operates on any voltage worldwide. ... safety Interlock and easy load ... Double Spike Tubing, Dual Pneumatic ...
Medicine Products: